SEARCH

SEARCH BY CITATION

References

  • 1
    Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset pre-eclampsia. Hypertens Pregnancy 2000;19: 221231.
  • 2
    Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169: 10001006.
  • 3
    Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe pre-eclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171: 818822.
  • 4
    Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe pre-eclampsia between 28–34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990;76: 10701075.
  • 5
    van Pampus MG, Wolf H, Westenberg SM, van der Post JA, Bonsel GJ, Treffers PE. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1998;76: 3136.
  • 6
    Hall DR, Odendaal HJ, Kirsten GF, Smith J, Grove D. Expectant management of early onset, severe pre-eclampsia: perinatal outcome. BJOG 2000;107: 12581264.
  • 7
    Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000;107: 12521257.
  • 8
    Cloeren SE, Lippert TH. Effect of plasma expanders in toxemia of pregnancy. N Engl J Med 1972;287: 13561357.
  • 9
    Visser W, van Pampus MG, Treffers PE, Wallenburg HC. Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1994;53: 175181.
  • 10
    Hubner F, Sander C. Dopplersonographische Befunde unter Hamodilution mit Hydroxyathylstarke bei intrauteriner fetaler Retardierung. Doppler ultrasound findings in hemodilution with hydroxyethyl starch in intrauterine fetal retardation. Geburtshilfe Frauenheilkd 1995;55: 8792.
  • 11
    Karsdorp VH, van Vugt JM, Dekker GA, van Geijn HP. Reappearance of end-diastolic velocities in the umbilical artery following maternal volume expansion: a preliminary study. Obstet Gynecol 1992;80: 679683.
  • 12
    Heilmann L. Klinische Ergebnisse nach Hamodilution mit Hydroxyathylstarke in der Schwangerschaft. Clinical results after hemodilution with hydroxyethyl starch in pregnancy. Z Geburtshilfe Perinatol 1989;193: 219225.
  • 13
    Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of women with pre-eclampsia. Cochrane Database Syst Rev 2000;124: CD001805.
  • 14
    Young PF, Leighton NA, Jones PW, Anthony J, Johanson RB. Fluid management in severe pre-eclampsia (VESPA): survey of members of ISSHP. Hypertens Pregnancy 2000;19: 249259.
  • 15
    Gulmezoglu AM, Hofmeyr GJ. Plasma volume expansion for suspected impaired fetal growth. Cochrane Database Syst Rev 2000: CD000167.
  • 16
    Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158: 892898.
  • 17
    Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990;162: 311316.
  • 18
    Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992;339: 283287.
  • 19
    Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82: 527532.
  • 20
    Volpe JJ. Intraventricular hemorrhage and brain injury in the premature infant. Diagnosis, prognosis, and prevention. Clin Perinatol 1989;16: 387411.
  • 21
    De Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992;49: 16.
  • 22
    Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33: 179201.
  • 23
    Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. Am J Obstet Gynecol 1985;151: 333337.
  • 24
    Prechtl HFR, Beintema D. The Neurological Examination of the Full-Term Newborn Infant. London: Spastics International Medical Publications/William Heinemann Medical Books, 1964.
  • 25
    Touwen BC, Huisjes HJ, Jurgens-van der Zee AD, Bierman-van Eendenburg ME, Smrkovsky M, Olinga AA. Obstetrical condition and neonatal neurological morbidity. An analysis with the help of the optimality concept. Early Hum Dev 1980;4: 207228.
  • 26
    Maas YG, Mirmiran M, Hart AA, Koppe JG, Ariagno RL, Spekreijse H. Predictive value of neonatal neurological tests for developmental outcome of preterm infants. J Pediatr 2000;137: 100106.
  • 27
    Olah KS, Redman CW, Gee H. Management of severe, early pre-eclampsia: is conservative management justified? Eur J Obstet Gynecol Reprod Biol 1993;51: 175180.
  • 28
    Visser W, Wallenburg HC. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995;63: 147154.
  • 29
    Scherjon SA, Smolders-DeHaas H, Kok JH, Zondervan HA . The Brain-sparing effect. Antenatal cerebral Doppler findings in relation to neurologic outcome in very preterm infants. Am J Obstet Gynecol 1993;169: 169175.
  • 30
    Friedman SA, Schiff E, Kao L, Sibai BM. Neonatal outcome after preterm delivery for pre-eclampsia. Am J Obstet Gynecol 1995;172: 17851788.
  • 31
    Vigil-De Gracia P, Montufar-Rueda C, Ruiz J. Expectant management of severe pre-eclampsia and pre-eclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. Eur J Obstet Gynecol Reprod Biol 2003;107: 2427.
  • 32
    Schaap AH, Wolf H, Bruinse HW, et al. Fetal distress due to placental insufficiency at 26 through 31 weeks: a comparison between an active and a more conservative management. Eur J Obstet Gynecol Reprod Biol 1996;70: 6168.
  • 33
    Levene MI, Fawer CL, Lamont RF. Risk factors in the development of intraventricular haemorrhage in the preterm neonate. Arch Dis Child 1982;57: 410417.
  • 34
    Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004;364: 513520.
  • 35
    The GRIT study group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 2003;110: 2732.
  • 36
    Withagen MI, Visser W, Wallenburg HC. Neonatal outcome of temporizing treatment in early-onset pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2001;94: 211215.
  • 37
    Belfort M, Uys P, Dommisse J, Davey DA. Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy. Br J Obstet Gynaecol 1989;96: 634641.
  • 38
    Lowe SA, Hetmanski DJ, Macdonald I, Pipkin FB, Rubin PC. Intravenous volume expansion therapy in pregnancy-induced hypertension: the role of vasoactive hormones. Hypertens Pregnancy 1993;12: 139151.
  • 39
    Sehgal NN, Hitt JR. Plasma volume expansion in the treatment of pre-eclampsia. Am J Obstet Gynecol 1980;138: 165168.
  • 40
    Heilmann L, Gerhold S, von Tempelhoff GF, Pollow K. The role of intravenous volume expansion in moderate pre-eclampsia. Clin Hemorheol Microcirc 2001;25: 8389.
  • 41
    Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003;348: 514.
  • 42
    Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2000: CD001449.
  • 43
    Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy [Cochrane review]. Cochrane Database Syst Rev 2001;2: CD002252.
  • 44
    Samsom JF, de Groot L, Bezemer PD, Lafeber HN, Fetter WP. Muscle power development during the first year of life predicts neuromotor behaviour at 7 years in preterm born high-risk infants. Early Hum Dev 2002;68: 103118.